| Tyyppi : |
Lehti |
|
| Tutkimus Joukkueet : |
Gand - laboratory of Pharmaceutical technology, State University of Gent |
| Tekijät : |
Huyghebaert N, de Beer J, Vervaet C et al. |
| Otsikko : |
Compounding of vitamin A, D3, E, and K3 supplements for cystic fibrosis patients: formulation and stability study. |
| Numero : |
J Clin Pharm Ther ; 32: 489-496. 2007 |
|
| Todisteiden määrä : |
|
| Fyysinen vakaus : |
|
| Kemiallinen stabiilisuus : |
|
| Muut menetelmät : |
|
| Commentairesvaleur : |
|
Luettelo yhdisteistä
 Alpha-tocopherol acetate
|
 |
 |
 |
 |
100 mg
Alpha tocophérol acétate |
|
25°C |
 |
| 60 |
 |
|
|
|
|
|
100 mg
Alpha tocophérol acétate |
|
8°C |
 |
| 60 |
|
|
|
|
|
Cholecalciferol
|
|
|
|
|
1000 UI
Cholecalciferol |
|
25°C |
|
| 60 |
|
|
|
|
|
|
1000 UI
Cholecalciferol |
|
8°C |
|
| 60 |
|
|
|
|
|
Menadione
|
|
|
|
|
1 mg
Menadione |
|
25°C |
|
| 60 |
|
|
|
|
|
|
1 mg
® ? = DMS |
|
8°C |
|
| 60 |
|
|
|
|
|
Retinol
|
|
|
|
|
10 000 UI
retinol acetate |
|
25°C |
|
| 60 |
|
|
|
|
|
|
10 000 UI
Retinol acetate |
|
8°C |
|
| 60 |
|
|
|
|
|
